← Back to Search

Dietary and Nutritional Interventions for Post-Concussion Syndrome

N/A

Recruiting

Led By Stephanie Ward Chiasson, PhD, RD

Research Sponsored by Universite de Moncton

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and endpoint (week 8)

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to assess the impact of dietary & nutritional interventions on post-concussion symptoms. Patients will be randomly assigned to receive different treatments. Symptoms will be monitored over 8 weeks.

Who is the study for?

This trial is for adults in New Brunswick, Canada, who have had post-concussive symptoms for 2 weeks to 6 months. Participants must understand English or French and be over the age of 16. It excludes those with other neurological disorders, moderate/severe brain injury history, active inflammatory bowel disease, conditions preventing physiotherapy, and pregnant or breastfeeding women.

What is being tested?

The study tests if dietetic counseling plus supplements (omega-3, vitamin D3 & creatine) can improve persistent concussion symptoms compared to just supplements or only physiotherapy. Patients are randomly assigned to one of these three groups and monitored through questionnaires over eight weeks.

What are the potential side effects?

Potential side effects may include digestive issues due to dietary changes or supplements and typical risks associated with physiotherapy such as muscle soreness or fatigue.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and endpoint (week 8)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and endpoint (week 8)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and endpoint (week 8) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Interventional procedure

Secondary study objectives

Interventional procedure

Change from baseline in vestibular ocular motor at the end of the intervention

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Physiotherapy treatment (control group)Experimental Treatment1 Intervention

Patients in the control group will receive physiotherapy treatments over eight weeks.

Group II: Dietary intervention and nutritional supplements (group A)Experimental Treatment3 Interventions

Patients in group A will receive four consultations with a dietitian over eight weeks, in addition to conventional physiotherapy treatments. These patients will receive nutritional counselling and omega-3 (2500mg/day), vitamin D (2000 IU/day) and creatine monohydrate (10mg/day) supplements prescribed by their doctor.

Group III: Nutritional supplements (group B)Active Control2 Interventions

Patients in group B will be prescribed omega-3 (2500mg/day), vitamin D (2000 IU/day) and creatine monohydrate (10mg/day) supplements and receive physiotherapy treatments over eight weeks.

Do I qualify?Apply below to find out